Articles with "associated hepatocellular" as a keyword



Hepatitis B-associated hepatocellular carcinoma in a young Haitian man: a review of screening guidelines

Sign Up to like & get
recommendations!
Published in 2019 at "BMJ Case Reports"

DOI: 10.1136/bcr-2019-230530

Abstract: Hepatocellular carcinoma (HCC) is a terminal, yet preventable, outcome of untreated infection with hepatitis B virus (HBV). HBV is endemic in many areas of Latin America and the Caribbean, including Haiti. Haitians have the highest… read more here.

Keywords: hepatocellular carcinoma; carcinoma young; hepatitis associated; associated hepatocellular ... See more keywords

Predictive power of splenic thickness for post-hepatectomy liver failure in HBV-associated hepatocellular carcinoma patients

Sign Up to like & get
recommendations!
Published in 2017 at "World Journal of Surgical Oncology"

DOI: 10.1186/s12957-017-1281-6

Abstract: BackgroundThe purpose of this case series is to investigate the relationship between splenic thickness (ST) and postoperative outcomes after hepatic resection in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) patients.MethodsThe clinical data of 320 patients… read more here.

Keywords: hepatocellular carcinoma; hbv associated; hepatectomy; liver ... See more keywords

The Effect of Metabolic Syndrome on the Outcome of Hepatitis B-Associated Hepatocellular Carcinoma Patients After Hepatectomy: A Multicenter Study

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.811084

Abstract: Background and Aims With changes in dietary patterns and modern lifestyles, the prevalence of metabolic syndrome (MetS) in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) patients is increasing. The purpose of our study is to… read more here.

Keywords: hepatocellular carcinoma; metabolic syndrome; hcc group; associated hepatocellular ... See more keywords

CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14020454

Abstract: Simple Summary CD26/DPP4 has been reported to attenuate anticancer immunity via chemokine cleavage and to promote insulin resistance and inflammation in the liver and/or adipose tissue via dysregulation of macrophage M1/M2 polarization. These results suggest… read more here.

Keywords: hepatocellular carcinoma; dpp4; nonalcoholic steatohepatitis; associated hepatocellular ... See more keywords

Clinical Characteristics of Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients in Southwest Nigeria

Sign Up to like & get
recommendations!
Published in 2025 at "Pathogens"

DOI: 10.3390/pathogens14020169

Abstract: Hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality in West Africa, but its presentation is poorly understood. In this study, we describe the clinical characteristics of HBV-associated HCC… read more here.

Keywords: hepatocellular carcinoma; clinical characteristics; hepatitis virus; associated hepatocellular ... See more keywords

The Adaptive Immune Response in Hepatitis B Virus-Associated Hepatocellular Carcinoma Is Characterized by Dysfunctional and Exhausted HBV-Specific T Cells

Sign Up to like & get
recommendations!
Published in 2024 at "Viruses"

DOI: 10.3390/v16050707

Abstract: This systematic review investigates the immunosuppressive environment in HBV-associated hepatocellular carcinoma (HCC), characterized by dysfunctional and exhausted HBV-specific T cells alongside an increased infiltration of HBV-specific CD4+ T cells, particularly regulatory T cells (Tregs). Heightened… read more here.

Keywords: hbv; associated hepatocellular; dysfunctional exhausted; characterized dysfunctional ... See more keywords

Immune checkpoint inhibitors plus anti-angiogenesis in patients with resected high-risk hepatitis B virus-associated hepatocellular carcinoma

Sign Up to like & get
recommendations!
Published in 2025 at "World Journal of Gastrointestinal Oncology"

DOI: 10.4251/wjgo.v17.i4.101371

Abstract: BACKGROUND Currently, there is a lack of effective adjuvant therapies for patients at high-risk of recurrent hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) after radical resection. Given the efficacy of anti-programmed death 1/anti-programmed death ligand 1… read more here.

Keywords: treatment; hepatitis virus; associated hepatocellular; risk ... See more keywords